A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials

Sarecycline is a novel, narrow-spectrum, third generation tetracycline class antibiotic approved by the Food and Drug Administration (FDA) for the treatment of moderate-to-severe acne in patients ages nine and older. Recently, focus has increased on whether treatment responses differ in acne in skin...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Angela Yen, Hurley, Kara, Moore, Stephen Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854598/
https://www.ncbi.nlm.nih.gov/pubmed/36671290
http://dx.doi.org/10.3390/antibiotics12010089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854598/
https://www.ncbi.nlm.nih.gov/pubmed/36671290
http://dx.doi.org/10.3390/antibiotics12010089

Ejemplares similares